- Home
- SXTC vs NUWE Comparison
SXTC vs NUWE Comparison
Compare SXTC & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTC | NUWE |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | China | United States |
| Employees | N/A | 38 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 1.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | SXTC | NUWE |
|---|---|---|
| Price | $1.36 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.5K | ★ 76.6K |
| Earning Date | 08-19-2019 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.14 |
| Revenue Next Year | N/A | $18.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.19 |
| 52 Week High | $6.98 | $25.95 |
Technical Indicators
Market Signals| Indicator | SXTC | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 36.46 | 35.88 |
| Support Level | $1.11 | $0.20 |
| Resistance Level | $1.58 | $2.86 |
| Average True Range (ATR) | 0.15 | 0.14 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 0.00 | 31.48 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.